Novandi Chemistry is today awarded a monetary prize by the Sten Gustafsson Foundation at the Royal Academy of Engineering Sciences (IVA). The foundation was established in 1993 by AB Astra (now AstraZeneca) in honor of Sten Gustafsson’s invaluable contribution to Swedish industry. Alongside Novandi Chemistry is also the Södertälje based research company MetaSafe awarded.
– We are pleased and proud to support two promising Södertalje-based research companies founded by former employees at AstraZeneca´s abandoned research center, says Björn O. Nilsson, Professor, President of IVA and member of the distribution committee.
– MetaSafe and Novandi Chemistry show that in Södertälje are new and strong companies based on the cities high drug competence. It feels good that the foundation can help them, says Sten Gustafsson, President of the Sten Gustafsson Foundation.
– At AstraZeneca, we are pleased with the large number of high quality applications received and we are impressed by the fact that there are already exciting companies that are now benefiting from Sten Gustafsson’s fund, said Anders Ekblom, CEO of AstraZeneca Sweden AB, also a member of the distribution committee.
Sten Gustafsson, born in 1923, was the president of Astra AB from 1955 to 1957, vice president from 1957 to 1963 and chairman from 1983 to 1990. He was elected in 1972 in IVA and was the Academy preses 1986-1988.
For the full press release from the Royal Academy of Engineering Sciences (IVA) please go here.
From left to right; Anders Ekblom, CEO of AstraZeneca Sweden AB, Johan Sandell, CEO of Novandi Chemistry AB, Sten Gustafsson, Chairman Sten Gustafsson’s Foundation, Johanna Haglund, CEO of MetaSafe, and Björn O. Nilsson, President of IVA.